Search

Search Constraints

You searched for: Author/Creator Magerl, Markus

Search Results

1. An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial. Issue 10375 (11th February 2023)

2. An open‐label study to evaluate the long‐term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension. Issue 1 (6th October 2017)

3. Analysis of genetic impact on smell impairment in patients with hereditary angioedema type 1 and 2. (20th May 2021)

4. Automatic screening of self‐evaluation apps for urticaria and angioedema shows a high unmet need. Issue 12 (9th September 2021)

6. Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis. Issue 10 (18th December 2021)

8. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence. Issue 8 (27th April 2020)

9. Development of the Angioedema Control Test—A patient‐reported outcome measure that assesses disease control in patients with recurrent angioedema. Issue 5 (6th March 2020)